Strong Balance SheetLow leverage and a strong equity base provide durable financial flexibility, allowing the company to fund operations, absorb shocks, and invest in product development or distribution without relying heavily on external debt. This supports long-term stability and strategic optionality.

Consistent Revenue GrowthSustained top-line growth indicates steady demand across its product lines and effective commercial execution. Over 2-6 months this implies expanding market penetration and recurring revenue potential, which supports reinvestment in brands and channels and underpins long-term cash generation.

Diversified Healthcare PortfolioA multi-segment footprint (branded formulations, consumer healthcare, devices) reduces reliance on a single product or channel, smoothing revenue cyclicality and allowing cross-selling to institutional and retail channels. Diversification improves resilience and strategic growth options.

Bears Say

Negative Operating Cash FlowPersistent negative operating cash flow undermines the firm's ability to self-fund working capital, capex, dividends or M&A without raising external funds. Over months this can constrain growth initiatives, increase financing cost, and pressure liquidity if not corrected.

Declining EBITDA MarginEroding operating margins point to cost pressure or reduced operating leverage, which can persist and compress free cash generation. If structural, margin decline limits capacity to reinvest in R&D, marketing or price competitiveness, weakening long-term profitability.

Falling EPSA marked drop in EPS signals profit per share deterioration, reflecting margin, cost or non-recurring pressures. Over the medium term this can reduce retained earnings, limit shareholder returns, and raise scrutiny on management execution unless operational improvements restore earnings power.

TTK Healthcare Limited News

TTK Healthcare Seeks Shareholder Nod via E-Voting to Appoint New Independent Director

TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) has issued an announcement. TTK Healthcare Limited has launched a postal ballot...

2M ago

TTK Healthcare Board Appoints New Independent Director, Seeks Shareholder Nod via Postal Ballot

An update from TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) is now available. TTK Healthcare Limited’s board has approved...

2M ago

TTKHLTCARE FAQ

What was TTK Healthcare Limited’s price range in the past 12 months?

TTK Healthcare Limited lowest stock price was ₹906.30 and its highest was ₹1402.00 in the past 12 months.

What is TTK Healthcare Limited’s market cap?

TTK Healthcare Limited’s market cap is ₹12.96B.

When is TTK Healthcare Limited’s upcoming earnings report date?

TTK Healthcare Limited’s upcoming earnings report date is May 22, 2026 which is in 84 days.

How were TTK Healthcare Limited’s earnings last quarter?

TTK Healthcare Limited released its earnings results on Jan 22, 2026. The company reported ₹7.454 earnings per share for the quarter, beating the consensus estimate of N/A by ₹7.454.

Is TTK Healthcare Limited overvalued?

According to Wall Street analysts TTK Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does TTK Healthcare Limited pay dividends?

TTK Healthcare Limited pays a Annually dividend of ₹10 which represents an annual dividend yield of 0.95%. See more information on TTK Healthcare Limited dividends here

What is TTK Healthcare Limited’s EPS estimate?

TTK Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TTK Healthcare Limited have?

TTK Healthcare Limited has 14,130,333 shares outstanding.

What happened to TTK Healthcare Limited’s price movement after its last earnings report?

TTK Healthcare Limited reported an EPS of ₹7.454 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.839%.

Which hedge fund is a major shareholder of TTK Healthcare Limited?

Currently, no hedge funds are holding shares in IN:TTKHLTCARE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

TTK Healthcare Limited

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.